| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 46 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 46 |
| 2 | TACROLIMUS OINTMENT 0.1% | 46 |
| 3 | PREDNISONE | 43 |
| 4 | CLOTRIMAZOLE | 41 |
| 5 | CLOTRIMAZOLE TOPICAL | 41 |
| 6 | DRS. CLOTRIMAZOLE | 41 |
| 7 | FAMILY WELLNESS CLOTRIMAZOLE | 41 |
| 8 | VALGANCICLOVIR | 41 |
| 9 | VALGANCICLOVIR HYDROCHLORIDE | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOTRIMAZOLE TOPICAL | 41 | 0.0035 |
| 1 | CLOTRIMAZOLE | 41 | 0.0033 |
| 2 | VALGANCICLOVIR | 41 | 0.0021 |
| 3 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 4 | STREPTOMYCIN | 1 | 0.0009 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | TACROLIMUS OINTMENT 0.1% | 46 | 0.0004 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 46 | 0.0004 |
| 8 | AZILSARTAN KAMEDOXOMIL | 1 | 0.0003 |
| 9 | TACROLIMUS | 46 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 41 | 0.0018 |
| 1 | Azole Antifungal [EPC] | 41 | 0.0003 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 3 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 14 | 0.0001 |
| 4 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 46 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |